Cargando…
_version_ 1783282834298896384
author Pleniceanu, Oren
Shukrun, Racheli
Omer, Dorit
Vax, Einav
Kanter, Itamar
Dziedzic, Klaudyna
Pode‐Shakked, Naomi
Mark‐Daniei, Michal
Pri‐Chen, Sara
Gnatek, Yehudit
Alfandary, Hadas
Varda‐Bloom, Nira
Bar‐Lev, Dekel D
Bollag, Naomi
Shtainfeld, Rachel
Armon, Leah
Urbach, Achia
Kalisky, Tomer
Nagler, Arnon
Harari‐Steinberg, Orit
Arbiser, Jack L
Dekel, Benjamin
author_facet Pleniceanu, Oren
Shukrun, Racheli
Omer, Dorit
Vax, Einav
Kanter, Itamar
Dziedzic, Klaudyna
Pode‐Shakked, Naomi
Mark‐Daniei, Michal
Pri‐Chen, Sara
Gnatek, Yehudit
Alfandary, Hadas
Varda‐Bloom, Nira
Bar‐Lev, Dekel D
Bollag, Naomi
Shtainfeld, Rachel
Armon, Leah
Urbach, Achia
Kalisky, Tomer
Nagler, Arnon
Harari‐Steinberg, Orit
Arbiser, Jack L
Dekel, Benjamin
author_sort Pleniceanu, Oren
collection PubMed
description [Image: see text]
format Online
Article
Text
id pubmed-5709741
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57097412017-12-06 Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target Pleniceanu, Oren Shukrun, Racheli Omer, Dorit Vax, Einav Kanter, Itamar Dziedzic, Klaudyna Pode‐Shakked, Naomi Mark‐Daniei, Michal Pri‐Chen, Sara Gnatek, Yehudit Alfandary, Hadas Varda‐Bloom, Nira Bar‐Lev, Dekel D Bollag, Naomi Shtainfeld, Rachel Armon, Leah Urbach, Achia Kalisky, Tomer Nagler, Arnon Harari‐Steinberg, Orit Arbiser, Jack L Dekel, Benjamin EMBO Mol Med Corrigendum [Image: see text] John Wiley and Sons Inc. 2017-12-01 2017-12 /pmc/articles/PMC5709741/ /pubmed/29196313 http://dx.doi.org/10.15252/emmm.201708507 Text en © 2017 The Authors
spellingShingle Corrigendum
Pleniceanu, Oren
Shukrun, Racheli
Omer, Dorit
Vax, Einav
Kanter, Itamar
Dziedzic, Klaudyna
Pode‐Shakked, Naomi
Mark‐Daniei, Michal
Pri‐Chen, Sara
Gnatek, Yehudit
Alfandary, Hadas
Varda‐Bloom, Nira
Bar‐Lev, Dekel D
Bollag, Naomi
Shtainfeld, Rachel
Armon, Leah
Urbach, Achia
Kalisky, Tomer
Nagler, Arnon
Harari‐Steinberg, Orit
Arbiser, Jack L
Dekel, Benjamin
Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target
title Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target
title_full Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target
title_fullStr Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target
title_full_unstemmed Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target
title_short Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target
title_sort peroxisome proliferator‐activated receptor gamma (pparγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709741/
https://www.ncbi.nlm.nih.gov/pubmed/29196313
http://dx.doi.org/10.15252/emmm.201708507
work_keys_str_mv AT pleniceanuoren peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT shukrunracheli peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT omerdorit peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT vaxeinav peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT kanteritamar peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT dziedzicklaudyna peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT podeshakkednaomi peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT markdanieimichal peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT prichensara peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT gnatekyehudit peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT alfandaryhadas peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT vardabloomnira peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT barlevdekeld peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT bollagnaomi peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT shtainfeldrachel peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT armonleah peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT urbachachia peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT kaliskytomer peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT naglerarnon peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT hararisteinbergorit peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT arbiserjackl peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget
AT dekelbenjamin peroxisomeproliferatoractivatedreceptorgammappargiscentraltotheinitiationandpropagationofhumanangiomyolipomasuggestingitspotentialasatherapeutictarget